Summary
•Chronic hepatitis B can be found in up to 8% of all
HIV-patients
•HBV/HIV coinfected patients show a faster progression to
cirrhosis and
increased liver-related mortality
•Do not forget to check
for HDV superinfection
•ARV in HIV/HBV
co-infected patients should include TDF and 3TC or FTC
•In patients with no HAART indication (>500/µl) early HAART still remains an option;
alternatives are PEG-IFN, or de novo adefovir/telbivudine
therapy